# Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes

> **NCT03248401** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Carotid Atherosclerosis

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03248401
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-26
- **Primary completion:** 2018-10-21
- **Final completion:** 2019-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248401, "Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03248401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*